New Treatments for Alzheimer’s disease: Why Early Diagnosis is Important

Join us for:
New Treatments for Alzheimer’s Disease: Why Early Diagnosis is Important
Friday, December 1st, 12 – 1PM via Zoom

Presenters:
* Gad Marshall, MD – Director of Clinical Trials at the BWH Center for Alzheimer Research and Treatment (CART)
* Dorene Rentz, PsyD – Co-Director, Outreach, Recruitment & Engagement Core at MADRC, Co-Director of CART
* Christine Ritchie, MD, MSPH – Co-Director, Outreach, Recruitment & Engagement Core at MADRC
*Mike Erkkinen, MD – Director BWH Division of Cognitive & Behavioral Neurology
*John Dickson, MD, PhD – Neurologist, MGH Memory Disorders Division
* Art Canter – Research Participant at MADRC

This program will explain:
* How lecanemab works & potential side effects
* Who could benefit from this new medication
* Treatment costs & insurance coverage options
* How patients may access the medication at MGB

To register: bit.ly/ADTreatments